Sort   by:  
 Page size 
UnknownComment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey: Reply.
Not available
S-EPMC11374017 | biostudies-literature
UnknownConsensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.
Not available
S-EPMC4116713 | biostudies-literature
UnknownType 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study.
Not available
S-EPMC10759717 | biostudies-literature
UnknownCOVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study.
Not available
S-EPMC11343807 | biostudies-literature
UnknownCOVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey.
Not available
S-EPMC11618185 | biostudies-literature
UnknownDeterminants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study.
Not available
S-EPMC11751688 | biostudies-literature
UnknownDisease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset.
Not available
S-EPMC12007600 | biostudies-literature
UnknownCOVAD survey 2 long-term outcomes: unmet need and protocol.
Not available
S-EPMC9376047 | biostudies-literature
UnknownHypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Anemia in Chronic Kidney Disease: Guidelines for South Asia.
Not available
S-EPMC11883314 | biostudies-literature
UnknownCOVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
Not available
S-EPMC10766674 | biostudies-literature
Sort   by:  
 Page size